Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
Public ClinicalTrials.gov record NCT01362621. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 2-year Prospective, Multi-center, Observational and Epidemiologic Outcomes Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study was designed to collect data about inadequately controlled moderate to severe allergic asthma in subjects 6 to \< 12 years of age, managed in a real-world setting.
Study identification
- NCT ID
- NCT01362621
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 474 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 6 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2008 (Type not available)
- Primary completion
- Feb 2010 (Actual)
- Completion
- Not listed
- Last update posted
- Jun 16, 2011
Started 2008
United States locations
- U.S. sites
- 50
- U.S. states
- 29
- U.S. cities
- 50
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novartis Investigative Site | Birmingham | Alabama | 35209 | — |
| Novartis Investigative Site | Crescent City | California | 95531 | — |
| Novartis Investigative Site | Fresno | California | 93726 | — |
| Novartis Investigative Site | Oakland | California | 94609 | — |
| Novartis Investigative Site | Orange | California | 92868 | — |
| Novartis Investigative Site | Roseville | California | 95678 | — |
| Novartis Investigative Site | Sacramento | California | 95819 | — |
| Novartis Investigative Site | San Diego | California | 92120 | — |
| Novartis Investigative Site | Walnut Creek | California | 94598 | — |
| Novartis Investigative Site | Thornton | Colorado | 80233 | — |
| Novartis Investigative Site | Albany | Georgia | 31707 | — |
| Novartis Investigative Site | Atlanta | Georgia | 30342 | — |
| Novartis Investigative Site | Columbus | Georgia | 31904 | — |
| Novartis Investigative Site | Savannah | Georgia | 31406 | — |
| Novartis Investigative Site | Evansville | Indiana | 47713 | — |
| Novartis Investigative Site | Topeka | Kansas | 66606 | — |
| Novartis Investigative Site | Cynthiana | Kentucky | 41031 | — |
| Novartis Investigative Site | Metarie | Louisiana | 70002 | — |
| Novartis Investigative Site | Burlington | Massachusetts | 01801 | — |
| Novartis Investigative Site | Kalamazoo | Michigan | 49008 | — |
| Novartis Investigative Site | Stevensville | Michigan | 49127 | — |
| Novartis Investigative Site | Minneapolis | Minnesota | 55402 | — |
| Novartis Investigative Site | Plymouth | Minnesota | 55441 | — |
| Novartis Investigative Site | Jackson | Mississippi | 39202 | — |
| Novartis Investigative Site | St Louis | Missouri | 63104 | — |
| Novartis Investigative Site | Omaha | Nebraska | 16945 | — |
| Novartis Investigative Site | Berkeley Heights | New Jersey | 07922 | — |
| Novartis Investigative Site | Brick | New Jersey | 08724 | — |
| Novartis Investigative Site | Summit | New Jersey | 07901 | — |
| Novartis Investigative Site | West Orange | New Jersey | 07052 | — |
| Novartis Investigative Site | Batavia | New York | 14020 | — |
| Novartis Investigative Site | Brooklyn | New York | 11229 | — |
| Novartis Investigative Site | Rockville Centre | New York | 11570 | — |
| Novartis Investigative Site | High Point | North Carolina | 27262 | — |
| Novartis Investigative Site | Toledo | Ohio | 43604 | — |
| Novartis Investigative Site | Oklahoma City | Oklahoma | 73112 | — |
| Novartis Investigative Site | Gresham | Oregon | 97030 | — |
| Novartis Investigative Site | Allentown | Pennsylvania | 18104 | — |
| Novartis Investigative Site | Altoona | Pennsylvania | 16601 | — |
| Novartis Investigative Site | Pittsburgh | Pennsylvania | 15212 | — |
| Novartis Investigative Site | Providence | Rhode Island | 02906 | — |
| Novartis Investigative Site | Kingsport | Tennessee | 37660 | — |
| Novartis Investigative Site | Dallas | Texas | 75230 | — |
| Novartis Investigative Site | Houston | Texas | 77054 | — |
| Novartis Investigative Site | Murray | Utah | 84107 | — |
| Novartis Investigative Site | South Burlington | Vermont | 05403 | — |
| Novartis Investigative Site | Emporia | Virginia | 23847 | — |
| Novartis Investigative Site | Norfolk | Virginia | 23507 | — |
| Novartis Investigative Site | Bellingham | Washington | 98225 | — |
| Novartis Investigative Site | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01362621, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 16, 2011 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01362621 live on ClinicalTrials.gov.